Clinical Trial Update: Trial of Hypofractionated Radiation Therapy for Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated radiation therapy for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED